Skip to main content
. 2024 Dec 2;14:29921. doi: 10.1038/s41598-024-80946-6

Table 1.

The summary Papp and ER calculated from transport study using gut MPS Data are presented as the mean ± SD (inhibitor (-): n = 4, inhibitor (+): n = 3).

Antipyrine Atenolol Midazolam Quinidine Sulfasalazine
Papp, basal to apical, inhibitor (-) (10−6 cm/s) 13.2 ± 1.1 not determined not determined 4.37 ± 0.15 6.44 ± 0.45
Papp, apical to basal, inhibitor (-) (10−6 cm/s) 20.1 ± 2.7 1.31 ± 0.19 11.2 ± 0.6 2.15 ± 0.33 0.505 ± 0.072
Papp, basal to apical, inhibitor (+) (10−6 cm/s) 14.4 ± 0.7 not determined not determined 4.37 ± 1.53 1.10 ± 0.29
Papp, apical to basal, inhibitor (+) (10−6 cm/s) 18.5 ± 1.2 0.865 ± 0.173 14.4 ± 1.9 3.88 ± 1.12 0.557 ± 0.095
Efflux ratio (ER), inhibitor (-) 0.656 ± 0.120 - - 2.02 ± 0.37 12.7 ± 2.3
Efflux ratio (ER), inhibitor (+) 0.780 ± 0.076 - - 1.12 ± 0.63 1.97 ± 0.76